1991 Diplomate, Endocrinology, Diabetes, and Metabolism Diabetes, Lipoproteins, and Atherosclerosis, Hilton Head, South Carolina. …
CURRICULUM VITAE
Abhimanyu Garg, MD
Business Address:
The University of Texas
Southwestern Medical Center
at Dallas
Center for Human Nutrition
5323 Harry Hines Boulevard, Y3-222
Dallas, Texas 75390-9052
Telephone: 214/648-2895
Telefax: 214/648-7150
email: Abhimanyugarg@Utsouthwesternedu
Education:
1972 Higher Secondary, Central Board of Secondary Education,
New Delhi, India Second position among more than
60,000 students Honors in Physics, Chemistry,
Biology and Mathematics
1973 Premedical, Delhi University, Delhi, India First position
1978 MB, BS, All India Institute of Medical Sciences, New
Delhi, India
1982 MD, Internal Medicine specialization All India
Institute of Medical Sciences, New Delhi, India
1983-85 Fellow, Division of Endocrinology and Metabolism,
University of Alabama at Birmingham, Birmingham, Alabama
1985-87 Fellow, Division of Endocrinology and Metabolism,
University of
Texas Southwestern Medical Center at Dallas
1989 Diplomate, American Board of Internal Medicine
1991 Diplomate, Endocrinology, Diabetes, and Metabolism
2001- Recertification, Diplomate, Endocrinology, Diabetes and
Metabolism
House Officerships:
1978 Intern, All India Institute of Medical Sciences, New
Delhi, India
1979-81 Resident, Department of Medicine, All India Institute of
Medical Sciences
1982-83 Senior Resident, Department of Medicine, All India
Institute of Medical Sciences
Academic Rank:
Jan88- Assistant Professor, Departments of Internal Medicine and
Aug93 Clinical Nutrition, University of Texas Southwestern
Medical Center at Dallas
Sep93- Associate Professor, Department of Internal Medicine
Aug99
Sep99 Professor, Department of Internal Medicine
Administrative Rank:
1988-96 Assistant Program Director, General Clinical Research
Center
1996- Associate Program Director, General Clinical Research
Center
1990-
Director, Diabetes Clinic, VA North Texas Health Care
System
2001- Chief, Division of Nutrition and Metabolic Diseases
Medical Licensure:
1988- State of Texas, License No H-3351
Committees and Activities:
1991-93 Member, Program Committee of the Council of Nutritional
Sciences and Metabolism, American Diabetes Association
1993-96 Member, Editorial Board, Diabetes Care
1995- Member, Editorial Board, Nutrition Metabolism and
Cardiovascular Diseases
2000-03 Member, Editorial Board, Journal of Clinical
Endocrinology and Metabolism
01 Member, Writing Committee of the American Diabetes
Associations technical review and position statement
titled Nutrition Recommendations and Principles for People
with Diabetes
2004- Associate Editor, Journal of Clinical Endocrinology and
Metabolism
National Review Committees:
June, 1999 Member, Research Centers in Minority Institutions
Special Emphasis Panel, NCRR, NIH
July, 1999 Ad hoc reviewer, AARR2, AIDS Study section, NIH
March, 2000 Ad hoc reviewer, AARR2, AIDS Study section, NIH
April, 2000 Member, NHLBI, NIH special emphasis panel on protease
inhibitor related atherosclerosis in HIV infection
November, 2000 Ad hoc reviewer, AARR2, AIDS Study section, NIH
November, 2001 Ad hoc reviewer, NHLBI, NIH
July, 2002 Reviewer, GCRC, Seattle, NCRR, NIH
April, 2003 Member, Special Emphasis Panel, NCCAM, NIH
November, 2004 Member, Special Emphasis Panel, CSR, NIH
July 2005 Member, Special Emphasis Panel, CSR, NIH
November 2005 Member, AIDS Clinical Special Emphasis Panel, CSR,
NIH
Professional Societies:
1988- American Diabetes Association
1989- American Federation of Medical Research
1989- Texas Medical Association
1989- American Heart Association
1989- Dallas County Medical Society
1995- AIIMSONIANS of America
1999- Endocrine Society
2000- American Society of Clinical Investigation
Life member American Association of
Physicians of Indian Origin
Honors and Awards:
1969-72 National Science Talent Search Scholarship
1969-77 Rotary Club Scholarship
1972-77 National Merit Scholarship
1974 Sir Dorabji Tata Memorial Trust Prize for the Best Student
in Biochemistry
1974-77 All India Institute of Medical Sciences Merit Scholarship
1977 DC Bhutani Gold Medal for the Best Student in
Ophthalmology
1991 Keynote Speaker at the 8th Japan Diabetes-Lipid Research
Seminar
1998 Keynote Speaker at the XXXVIII Annual Meeting of the
Mexican Society of Endocrinology
2000 Member, American Society for Clinical Investigation
2001 Endowed Chair in Human Nutrition Research, UT Southwestern
2002 All India Institute of Medical Sciences Silver Jubilee
Oration Award
2003 Plenary Lecture at the 8th Adiposcience Meeting, Osaka,
Japan
2004 Green Chair Oration, Texas Christian University, Fort
Worth, TX
2004 Most Distinguished
Teacher/Researcher Award, American
Association of Physicians of Indian Origin, San Diego, CA
Invited Presentations at the National and International meetings:
August, 1984 Management of diabetic ketoacidosis, International
Course in Diabetes Mellitus, the Medical Society of the
General Hospital of Mexico and the Pan-American Health
Organization, Mexico City, Mexico
January, 1989 Different fatty acids versus carbohydrates: Implications
for the Diabetes Diet, Council on Nutritional Sciences and
Metabolism, 36th Postgraduate Course of the American
Diabetes Association, Dallas, Texas
March, 1989 Dietary Treatment of Hyperlipidemia in Diabetes: The
roles of Carbohydrate and Monounsaturated Fatty Acids 23rd
International Research Symposium of the American Diabetes
Association Diabetes, Lipoproteins, and Atherosclerosis,
Hilton Head, South Carolina
October, 1989 Experience with HMG CoA reductase inhibitors in Diabetic
Patients Symposium on Risk Factors and Long-Term
Diabetic Complications Copenhagen, Denmark
November, 1989 Hypolipidemic therapy for dyslipidemia in patients with
non-insulin-dependent diabetes mellitus X International
Symposium on Drugs Affecting Lipid Metabolism Houston, TX
May, 1990 Hypercholesterolemia and Diabetes Mellitus: Amplification
of Cardiovascular Risk, Hypercholesterolemia in diabetes
mellitus: pathophysiology and therapy Satellite meeting of
the Societa Italiana di Diabetologia 13 Congresso
Nazionale, Pisa, Italy
July, 1990 Management of Dyslipidemia in NIDDM, Research Frontiers
in Atherosclerosis and Diabetes, Workshop organized by the
Juvenile Diabetes Foundation International, Surrey, UK
September, 1990 Role of Monounsaturated Fatty Acids in Nutrition for Non-
insulin Dependent Diabetes Mellitus 4th International
Colloquium on Mono-unsaturated Fatty Acids, Boston, MA
December, 1990 Management of Dyslipidemia in NIDDM,
India-USA Symposium
and Workshop on Endocrinology, Metabolism and Diabetes, New
Delhi, India
February, 1991 Diet, Hyperlipidemia and Heart Disease, Risk Factors for
Atherosclerosis and their Modification, The University of
British Columbia Conference, Vancouver, Canada
April, 1991 Diet and Drug Treatment of Hyperlipidemia in Diabetes,
Macrovascular Disease in Diabetes, Radioimmunoassay Core
Symposium, University of Washington, Seattle, Washington
June, 1991 Lipid-lowering Therapy and Macrovascular Disease in
Diabetes Mellitus, Macrovascular Complications of Diabetes
Mellitus, XIV International Diabetes Federation Satellite
Symposium, Charleston, South Carolina
June, 1991 Role of monounsaturated fatty acids in nutrition for
patients with non-insulin-dependent diabetes mellitus, the
14th International Diabetes Federation Congress, Washington
DC
August, 1991 Lipoprotein Metabolism in Diabetes Mellitus:
Effects of Diet and Drugs Special Lecture at the 8th Japan
Diabetes-Lipid Research Seminar, Tokyo, Japan
November, 1991 Should type II diabetics be on high carbohydrate/low fat
diets? No University of California San Francisco
Symposium Diabetes Mellitus: Controversies and Critical
Issues New York, NY
December, 1991 Treatment of lipid disorders in patients with diabetic
complications, Diabetes and Lipids Connection: novel
approaches to its diagnosis and treatment Medical
University of South Carolina Symposium, Charleston, SC
May, 1992 Management of dyslipidemia in diabetes, University of
Toronto Lipoprotein Group Seminar, St Michaels Hospital,
Toronto,Canada
September, 1992 Diabetes mellitus and monounsaturated fatty acids
International Symposium on Dietary Lipids and Insulin
Action Smolenice Castle, Czecho-Slovakia
October, 1992 A logical approach to treatment of hyperlipidemia in the
diabetic patient 3rd
Annual UAB Diabetes Symposium,
Treatment of Diabetes in the 90s University of Alabama
School of Medicine, Birmingham, AL
January, 1993 What are the treatments for lipid disorders in diabetes:
drug therapy Detection and management of lipid disorders
in diabetes: Consensus Development Conference, American
Diabetes Association, Irving, Texas
April, 1993 Hyperlipidemia in NIDDM: Can drug interventions make a
difference in the associated insulin resistance and
cardiovascular endpoints? Second Annual Diabetes
Workshop on Pathogenesis and Management of Noninsulin-
Dependent Diabetes: Gender, Age and Racial Perspectives
The Ohio State University, Columbus, OH
April, 1993 New Insights in Syndromes of Lipodystrophy Oklahoma
Medical Research Foundation, Oklahoma City, OK
June, 1993 Lipoprotein Metabolism Diabetes Mellitus in Aging
Third US-Italy Science and Technology Cooperation
Conference,
Ostuni, Italy
June, 1993 Treatment of Dyslipidemias in Diabetic Patients
Diabetes and Atherosclerosis Symposium, Porto, Portugal
June, 1993 High Fat Low Carbohydrate Diets Current Controversy:
Carbohydrate and Fat Council on Nutritional Sciences and
Metabolism, American Diabetes Association, Las Vegas,
Nevada
July, 1993 The NCEP 1993: Relevant issues in the management of
dyslipidemia in diabetic patients Third Annual Conference
on Diabetes, Mexico City, Mexico
Jul-Aug, 1993 Visiting Faculty, All India Institute of Medical Sciences,
New Delhi, India
May, 1994 Diet and Lipids in Diabetes Diabetes Update
University of Arkansas Medical Sciences College of
Medicine, Little Rock, Arkansas
June, 1994 Treatment of Lipid Disorders in Diabetes Leader for
the workshop at the American Diabetes Associations 54th
Scientific Session, New Orleans, Louisiana
September, 1994 Dyslipidemia in Diabetes in the
Session Current
controversies in Clinical Endocrinology The Royal
College of Physicians and Surgeons of Canada Meeting,
Toronto, Canada
November, 1994 Chairperson of the IInd International Insulin Resistance
and Atherosclerosis Symposium held in Fort Worth, TX
November, 1994 Management of Dyslipidemia in NIDDM Internal Medicine
Grand Rounds at the University of Texas Health Science
Center at San Antonio, Texas
June, 1995 Dietary and Pharmacological Therapy of Dyslipidemia in
Diabetes in the Seminar Dyslipidemia, Diabetes and Macro-
vascular Disease sponsored by the University of Texas
Health Science Center at San Antonio, Texas at Atlanta,
Georgia
June, 1995 Treatment of Dyslipidemia with Diabetes Co-leader for
the workshop at the American Diabetes Associations 55th
Scientific Session, Atlanta, Georgia
February, 1996 The Carbohydrate Debate: The ADA Position National
Symposium on Improving
Treatment Outcomes in NIDDM: the
Questions and Controversies Banff, Canada
February, 1996 Nutritional Therapy in the Diabetic Patient in the
Session entitled Nutrition in Chronic Diseases at the
XIIth International Congress of Dietetics, Manila,
Philippines
April, 1996 High-fat vs high carbohydrate diets: effects in patients
with diabetes in the Second International Conference on
Fats and Oil Consumption in Health and Disease: How we can
optimize dietary composition to combat metabolic
complication and decrease obesity, Dallas, Texas
November, 1996 Insulin resistance, diabetes and HDL in the
International Symposium on The role of HDL in Disease
Prevention, Fort Worth, Texas
August, 1997 Treatment of diabetic dyslipidemia in the Symposium
Role of statins in patients with hypertriglyceridemia at
Dallas, Texas
September, 1997 Insulin resistance and body fat distribution Endocrine
Grand Rounds at the UT Health Science Center, San Antonio,
Texas
September, 1997 Dietary monounsaturated fats for patients with diabetes
mellitus at the American College of Nutrition Meeting, New
York, NY
October, 1997 Management of hypertriglyceridemia Clinical
Endocrinology Update 1997 The Endocrine Society
Postgraduate Course, Dallas, TX
February, 1998 Genetic and metabolic basis of familial lipodystrophies
at the Endocrine Grand Rounds, NIH, Bethesda, Maryland
June, 1998 Optimal treatment of diabetic dyslipidemia Meet the
Professor Session at the American Diabetes Associations
Meeting at Chicago, Illinois
September, 1998 Lipodystrophies Internal Medicine Grand Rounds, UT
Southwestern Medical Center at Dallas, Dallas, Texas
October, 1998 The insulin resistance syndrome, triglyceridemia and
coronary disease at the 5th Annual Fall Symposium on
Atherosclerosis Prevention, Blowing Rock, North Carolina
November, 1998
Diet therapy for diabetic dyslipidemia in the program
New Horizons in Diabetes Management by the American
Diabetes Association, North Illinois Area, Chicago,
Illinois
November, 1998 Advances in the pathophysiology and treatment of diabetic
dyslipidemia keynote address at the XXXVIII Annual Meeting
of the Mexican Society of Endocrinology, Morelia, Mexico
May, 1999 Lipodystrophy Syndromes: Definition, Classification and
Genetics: In the Clinical Staff Conference, National
Institutes of Health entitled The importance of fat:
lipodystrophy, insulin resistance and diabetes at Bethesda
Maryland
June, 1999 Lipodystrophies at the symposium entitled
Lipodystrophy and lipoatrophic diabetes at the 81st Annual
Meeting of the Endocrine Society, San Diego, California
June, 1999 Genetic and acquired lipodystrophy syndromes at the Ist
International Workshop on Adverse Drug Reactions and
Lipodystrophy in HIV at San Diego, California
December, 1999 Lipodystrophies: Familial and Acquired at the Abbott
Laboratories Physician Forum, Abbott Laboratories, Abbott
Park, Illinois
March, 2000 Low Carbohydrate Diets for Diabetic Patients, Loma Linda
University, Loma Linda, California
March, 2000 Lipodystrophies Medicine Grand Rounds, Medical
University of South Carolina, Charleston, South Carolina
June, 2000 What is the proper diet for the hyperlipidemic Diabetic
patient American Diabetes Associations annual meeting at
San Antonio, Texas
July, 2000 Genetic Basis of Familial Lipodystrophies, Endocrine
Grand Rounds, Indiana University, Indianapolis, Indiana
August, 2000 Genetic Basis of Familial Lipodystrophies at the
Adipocyte Biology Meeting, Forum for Collaborative HIV
Research, Washington, DC
September, 2000 Lipodystrophy and Metabolic Syndrome in HIV-infected
Patients, Internal Medicine Grand Rounds, UT Southwestern
Medical Center at Dallas, Dallas, TX
November 2000 Lipid Management for a Lifetime, 37th Annual Diabetes
Symposium, Central Ohio Diabetes Association Ohio State
University, Columbus, Ohio
January 2001 Visiting Professor, All India Institute of Medical
Sciences, New Delhi, India
March 2001 Molecular and Metabolic Basis of Inherited
Lipodystrophies, Management of Dyslipidemia in Diabetics
Endocrine Research Seminar and Grand Rounds, Mayo Clinic,
Rochester, MN
March 2001 Overview of Clinical Syndromes of Lipodystrophies, 1st
International Workshop on Lipoatrophic diabetes and other
syndromes of lipodystrophy NIH, Bethesda, Maryland
May 2001 The Clinical Spectrum of Insulin Resistance: From
Lipodystrophy to Obesity, Symposium and Training IX:
Hepatic Gluconeogenesis, UT Southwestern Medical Center at
Dallas, Dallas, TX
June, 2001 Overview of familial partial lipodystrophy and its
variants American Diabetes Associations annual meeting at
Philadelphia, Pennsylvania
September, 2001 Lipodystrophies: old syndromes, new insights, Department
of Medicine Grand Rounds, Tulane University Health Sciences
Center, New Orleans, Louisiana
May, 2002 Molecular basis of lipodystrophies and other disorders of
adipose tissue Internal Medicine Grand Rounds, UT
Southwestern Medical Center at Dallas, Dallas, Texas
June, 2002 The new National Cholesterol Education Program ATP III
Guidelines; implications for diabetic patients, Diabetes
Update VI The Ohio State University Medical Center,
Columbus, Ohio
September, 2002 Lipodystrophies, Department of Pediatrics Grand Rounds,
University of Alabama at Birmingham, Birmingham, Alabama
September, 2002 Lipodystrophies and hepatic steatosis, American
Association for the Study of Liver Diseases Conference on
Nonalcoholic steatohepatitis Atlanta, Georgia
January, 2003 Adipose tissue disorders
and insulin resistance, 15th
AIIMS Silver Jubilee Oration, All India Institute of
Medical Sciences, New Delhi, India
February, 2003 Inherited and Acquired Lipodystrophies Endocrine Grand
Rounds at the University of Pittsburgh, Pittsburg, PA
March, 2003 Management of lipodystrophy in HIV-infected patients,
Plenary Lecture at the Community Programs for Clinical
Research on AIDS Science Retreat, Miami, FL
April, 2003 Molecular basis of congenital generalized lipodystrophy
Experimental Biology 2003 meeting, San Diego,
CA
May, 2003 Visiting Professor, Charles R Drew University, Los
Angeles, CA
June, 2003 Visceral fat is not most important in development of
diabetes American Diabetes Associations annual meeting at
New Orleans, Louisiana
August, 2003 Primary disorders of adipose tissue Plenary
Lecture at the 8th Adiposcience Meeting, Osaka, Japan
September 2003 Drug-induced Metabolic Syndrome American Heart
Associations Conference on Metaoblic Syndrome, Washington
DC
September 2003 Genetic and Acquired Lipodystrophies Longwood area
Diabetes/Metabolism Conference, Boston, MA
September 2003 Nutritional Management in Diabetes: Myths and Reality
Lilly Diabetes Update 2003, Amsterdam, Netherlands
October 2003 Addressing the challenges of Metabolic
Abnormalities in HIV Patients IDSA Satellite Symposium,
San Diego, CA
October 2003 Lipodystrophies, Old Syndromes, New Insights RW
Gunton Symposium, London, Ontario, Canada
January 2004 Genetic Basis of Lipodystrophies Plenary lecture
at the Western Society of Clinical Investigation Meeting,
Carmel, CA
April 2004 Genetic and Acquired Lipodystrophies Endocrine grand
round at the Beth Israel Hospital, Boston MA
June 2004 Lipodystrophic Syndromes Meet the Professor session at
the Endocrine Societys 86th Annual Meeting, New Orleans,
LA
August 2004 Genetic Factors
in the Pathogenesis of Fat Redistribution
Syndromes at the conference Metabolic
Disorders Associated with HIV-Infection and Drug Abuse
organized by the National Institute of Drug Abuse,
Bethesda, MD
September 2004 Lipodystrophy syndromes, International Congress of
Endocrinology, Lisbon, Portugal
November 2004 Metabolic Complications of Lipodystrophies Diabetes from
the Known Genetic Causes, Italian Society of Diabetology,
Bari, Italy
February 2005 Genetics of adipose tissue disorders Molecular Medicine
Symposium, Houston, Texas
March 2005 Nutritional Management of Diabetes All India Institute
of Medical Sciences, India
June 2005 Lipodystrophic Syndromes Meet the Professor session at
the Endocrine Societys 87th Annual Meeting, San Diego, CA
August 2005 Lipoprotein Disorders in Type 2 Diabetes Mellitus The
Barbara Davis Center for Diabetes symposium on
Practical Ways to Achieve Targets in Diabetes
Care, Keystone,
CO
November 2005 Lipodystrophies, insulin resistance and diabetes The
Progeria Reseach Foundation, Boston, MA
November 2005 Metabolic complications of lipodystrophies, Endocrine
Grand Rounds at the Duke University Medical Center,
Durham, NC
Current Grant Support:
NIH Grants:
DK54387 Garg 04/03 - 03/07 2,172,793 total
Genetic and Metabolic Basis of Familial Lipodystrophies
The major goals of this project are to identify additional genes
responsible for familial partial lipodystrophy Dunnigan variety and
congenital generalized lipodystrophy and to develop AGPAT1 and AGPAT2
gene knock out mouse models
DK56583 Garg 08/99 - 07/06
2,802,511 total
Mechanisms of Lipodystrophy in HIV-infected Patients
Mechanisms of Lipodystrophy in HIV-infected Patients
The major goals of this project are to identify molecular and
metabolic mechanisms responsible for lipodystrophy in HIV-infected
patients treated with HIV-1 protease inhibitors
DK63656 Garg 09/02 - 08/07
1,950,000 total
Mechanisms of Lipodystrophy in HIV-infected Patients
Therapeutic Approaches to HAART-Induced Lipodystrophy
The major goals of this project are to study safe and effective
therapeutic approaches for the management of lipodystrophy and
metabolic complications in HIV-infected patients treated with HIV-1
protease inhibitors
5M01-RR 00633-32 Ginsberg 04/04 - 03/09
15,610,179 total
General Clinical Research Center
The goal of this project is to provide the clinical research
infrastructure for investigators to conduct multi-disciplinary patient-
oriented research studies in both inpatient and outpatient settings
Role: Associate Program Director of the GCRC
Other Grants:
Amgen Inc Garg 3/03-2/06 72,000
Leptin replacement therapy in patients with lipodystrophy
Amgen Inc Garg 3/03-2/06 72,000
Double-blind placebo controlled trial of Leptin replacement therapy
in patients with lipodystrophy
Amgen Inc Garg 3/03-2/06 72,000
Efficacy of leptin treatment in HIV-1 protease inhibitor induced
lipodystrophy syndrome in HIV-infected patients
Doris Duke Charitable Foundation McPhaul 12/00-6/06
625,000
Doris Duke Clinical Research Fellowship Program for Medical Students
Role: Co-program leader
ORIGINAL PUBLICATIONS SPECIAL ARTICLES
1 Garg A, Kumar S, Kochupillai V Aplastic anemia in pregnancy Blut
45 2:143-144, 1982
2 Garg A, Gopinath PG, Pande JN, Guleria JS Role of radio-aerosol and
perfusion lung imaging in early detection of chronic obstructive lung
disease Eur J Nucl Med 8: 167-171, 1983
3 Garg A, Prakash K, Gopinath PG, Malaviya AN Radionuclide
oesophageal transit time in progressive systemic sclerosis PSS
Indian J Med Res 79: 110-113, 1984
4 Pati A, Khan A, Garg A, Dawar R, Sundaram KR, Kochupillai V COPP
Cyclophosphamide, Oncovin, Prednisolone and Procarbazine therapy in
Hodgkins disease: Experience at AIIMS Indian J Haematol 2 4: 231-
233, 1984
5 Garg A, Gopinath PG, Pande JN, Rustagi RK, Guleria JS Patterns of
radio-aerosol lung
scintiscanning in chronic obstructive lung disease
Indian J Chest Dis Allied Sci 26 3: 135-143, 1984
6 Garg A, Dawar R, Agarwal V, Rustagi RK, Kochupillai V Non-Hodgkins
lymphoma in northern India A retrospective analysis of 238 cases
Cancer 56 4: 972-977, 1985
7 Garg A, Kochupillai V Non-Hodgkins lymphoma in pregnancy South
Med
J 78 10: 1264-1265, 1985
8 Kapila K, Pande JN, Garg A, Verma K T lymphocyte subsets and B
lymphocytes in tubercular pleural effusion Indian J Chest Dis Allied
Sci 29: 90-93, 1987
9 Garg A, Grundy SM Lovastatin for lowering cholesterol in non-
insulin- dependent diabetes mellitus N Engl J Med 318: 81-86, 1988
10 Garg A, Bonanome A, Grundy SM, Zhang Z-J, Unger RH Comparison of a
high-carbohydrate diet with a high monounsaturated fat diet in
patients with non-insulin-dependent diabetes mellitus N Engl J Med
319: 829-834, 1988
11 Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock J, Raskin P
Relationship between lipoprotein levels and in vivo insulin action in
normal young white men Metabolism 37: 982-987, 1988
12
Garg A, Grundy SM Gemfibrozil alone and in combination with
lovastatin for treatment of hypertriglyceridemia in NIDDM Diabetes
38: 364-72, 1989 Errata published in Diabetes 39: 1313, 1990
13 Garg A, Bonanome A, Grundy SM, Unger RH, Breslau NA, Pak CYC
Effects of dietary carbohydrates on metabolism of calcium and other
minerals in normal subjects and patients with non-insulin-dependent
diabetes mellitus J Clin Endocrinol Metab 70: 1007-1013, 1990
14 Garg A, Grundy SM Nicotinic acid as therapy for dyslipidemia in non-
insulin-dependent diabetes mellitus JAMA 264: 723-726, 1990
15 Nozaki S, Garg A, Vega GL, Grundy SM Post-heparin lipolytic
activity and plasma lipoprotein response to -3 polyunsaturated fatty
acids in patients with primary hypertriglyceridemia Am J Clin Nutr
53: 638-642, 1991
16 Farese RV Jr, Garg A, Pierotti VR, Vega GL, Young SG A truncated
species of apolipoprotein B, B-83, associated with
hypobetalipoproteinemia J Lipid Res 33: 569-577, 1992
17 Garg A, Fleckenstein JL, Peshock RM, Grundy SM Peculiar
distribution of adipose tissue in patients with congenital generalized
lipodystrophy J Clin Endocrinol Metab 75: 358-361, 1992
18 Garg A, Grundy SM, Unger RH Comparison of effects of high and low
carbohydrate diets on plasma lipoproteins and insulin sensitivity in
patients with mild NIDDM Diabetes 41: 1278-1285, 1992
19 Fleckenstein JL, Garg A, Bonte FJ, Vuitch MF, Peshock RM The
skeleton in congenital, generalized lipodystrophy: evaluation using
whole-body radiographic surveys, magnetic resonance imaging and
technetium-99m bone scintigraphy Skeletal Radiology 21: 381-386,
1992
20 Garg A, Grundy SM, Koffler M Effect of high carbohydrate intake on
hyperglycemia, islet function, and plasma lipoproteins in NIDDM
Diabetes Care 15: 1572-1580, 1992
21 Garg A, Grizzle WE, Kansal PC, Stabler TV, Boots LR Counter-
regulatory hormone responses to insulin-induced acute hypoglycemia in
hypopituitary patients Horm Metab Res 26: 276-282, 1994
22 Garg A, Bantle JP, Henry RR, Coulston AM, Griver KA, Raatz SK,
Brinkley L, Chen Y-DI, Grundy SM, Huet BA,
Reaven GM Effects of
varying carbohydrate content of diet in patients with non-insulin-
dependent diabetes mellitus JAMA 271: 1421-1428, 1994
23 Abate N, Burns D, Peshock RM, Garg A, Grundy SM Estimation of
adipose tissue mass by magnetic resonance imaging: validation against
dissection in human cadavers J Lipid Res 35:1490-1496, 1994
24 Garg A, Grundy SM Cholestyramine therapy for dyslipidemia in non-
insulin-dependent diabetes mellitus Ann Intern Med 121:416-422, 1994
25 Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM
Relationships of generalized and regional adiposity to insulin
sensitivity in men J Clin Invest 96:88-98, 1995
26 Abate N, Garg A, Enas EA Physico-chemical properties of low density
lipoproteins in normolipidemic Asian Indian men Horm Metab Res 27:326-
331, 1995
27 Chandalia M, Garg A, Vuitch F, Nizzi F Postmortem findings in
congenital generalized lipodystrophy J Clin Endocrinol Metab 80:3077-
3081, 1995
28 Abate N, Vega GL, Garg A, Grundy SM Abnormal cholesterol
distribution among lipoprotein
fractions in normolipidemic patients
with mild NIDDM Atherosclerosis 118:111-122, 1995
29 Blades B, Garg A Mechanisms of increase in plasma triacylglycerol
concentrations as a result of high carbohydrate intakes in patients
with non-insulin-dependent diabetes mellitus Am J Clin Nutr 62:996-
1002,1995
30 Shah M, Baxter JE, McGovern PG, Garg A Nutrient and food intake in
obese women on a low-fat or low-calorie diet Am J Health Promot
10:179-182, 1996
31 Garg A, Chandalia M, Vuitch F Severe islet amyloidosis in
congenital generalized lipodystrophy Diabetes Care 19:28-31,1996
32 Yagalla MV, Hoerr SL, Song WO, Enas E, Garg A Relationship of diet,
abdominal obesity, and physical activity to plasma lipoprotein levels
in Asian Indian physicians residing in the United States J Am Diet
Assoc 96:257-261,1996
33 Fuller CJ, Chandalia M, Garg A, Grundy SM, Jialal I RRR–
tocopheryl acetate supplementation at pharmacologic doses decreases
low-density- lipoprotein oxidative susceptibility but not protein
glycation in patients with diabetes mellitus
Am J Clin Nutr 63:753-
759,1996
34 Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy
SM Relationship of generalized and regional adiposity to insulin
sensitivity in men with NIDDM Diabetes 45:1684-1693, 1996
35 Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S Coronary
heart disease and its risk factors in first-generation immigrant Asian
Indians to the United States of America Indian Heart J 48:343-
353,1996
36 Abate N, Garg A, Coleman R, Grundy SM, Peshock RM Prediction of
total subcutaneous abdominal, intraperitoneal, and retroperitoneal
adipose tissue masses in men by a single axial magnetic resonance
imaging slice Am J Clin Nutr 65:403-408,1997
37 Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, Grundy SM
Relationship of anterior and posterior subcutaneous abdominal fat to
insulin sensitivity in nondiabetic men Obes Res 5:93-97,1997
38 Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A
Localization of the gene for familial partial lipodystrophy Dunnigan
variety to chromosome 1q21-22 Nature
Genetics 18:292-295,1998
39 Garg A, Peshock RM, Fleckenstein JL Adipose tissue distribution
pattern in patients with familial partial lipodystrophy Dunnigan
variety J Clin Endocrinol Metab 84:170-174, 1999
40 Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK,
McGarry JD, Stein DT Measurement of intracellular triglyceride
stores by 1H spectroscopy: validation in vivo Am J Physiol 276: E977-
E989, 1999
41 Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM
Relationship between generalized and upper body obesity to insulin
resistance in Asian Indian men J Clin Endocrinol Metab 84:2329-2335,
1999
42 Garg A, Wilson R, Barnes R, Arioglu E, Zaidi Z, Gurakan F, Kocak N,
ORahilly S, Taylor SI, Patel SB, Bowcock AM A gene for congenital
generalized lipodystrophy maps to human chromosome 9q34 J Clin
Endocrinol Metab 84: 3390-3394, 1999
43 Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI,
Lovett M, Bowcock AM Mutational and haplotype analyses of families
with familial partial lipodystrophy Dunnigan
variety reveal
recurrent missense mutations in the globular C-terminal domain of
Lamin A/C Am J Hum Genet 66; 1192-1198, 2000
44 Garg A Gender differences in the prevalence of metabolic
complications in familial partial lipodystrophy Dunnigan variety J
Clin Endocrinol Metab 85: 1776-1782, 2000
45 Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley
LJ Beneficial effects of high dietary fiber intake in patients with
type 2 diabetes mellitus N Engl J Med 342; 1392-1398, 2000
46 Garg A, Stray-Gundersen J, Parsons D, Bertocci LA Skeletal muscle
morphology and exercise response in congenital generalized
lipodystrophy Diabetes Care 23; 1545-1550, 2000
47 Garg A, Vinaitheerthan M, Weatherall PT, Bowcock AM Phenotypic
heterogeneity in patients with familial partial lipodystrophy
Dunnigan variety related to the site of mis-sense mutations in Lamin
A/C LMNA gene J Clin Endocrinol Metab 86:59-65, 2001
48 Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson J-L, Garg A,
Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD,
Purnell JQ,
Wheeler M Evidence-based nutrition principles and recommendations for
the treatment and prevention of diabetes and related complications
Diabetes Care 25; 148-198, 2002
Agarwal AK, Garg A A novel heterozygous mutation in peroxisome
proliferator-activated receptor- gene in a patient with familial
partial lipodystrophy J Clin Endocrinol Metab 87:408-411, 2002
Simha V, Garg A Body fat distribution and metabolic derangements in
patients with familial partial lipodystrophy associated with
mandibuloacral dysplasia J Clin Endocrinol Metab 87; 776-785, 2002
Garg A, Speckman RA, Bowcock AM Multisystem dystrophy syndrome due to
novel missense mutations in the amino-terminal head and alpha-helical
rod domains of the lamin A/C gene Am J Med 112:549-555, 2002
Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ,
DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A Leptin-
replacement therapy for lipodystrophy N Engl J Med 346: 570-578,
2002
Haque WA, Shimomura I, Matsuzawa Y, Garg A Serum adiponectin and
leptin levels in patients with lipodystrophies J Clin Endocrinol
Metab 87: 2395-2398, 2002
49 Agarwal AK, Arioglu E, de Almeida S, Akkoc N, Taylor SI, Bowcock AM,
Barnes RI, Garg A AGPAT2 is mutated in congenital generalized
lipodystrophy linked to chromosome 9q34 Nature Genetics 31:21-23,
2002
50 Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM Sex Steroid
Hormones, Upper Body Obesity, and Insulin Resistance J Clin
Endocrinol Metab 87:4522-4527, 2002
51 Haque WA, Vuitch F, Garg A Post-mortem findings in familial partial
lipodystrophy, Dunnigan variety Diabetic Medicine 19: 1022-1025,
2002
Simha V, Zerwekh JE, Sakhaee K, and Garg A Effect of subcutaneous
leptin replacement therapy on bone metabolism in patients with
generalized lipodystrophy J Clin Endocrinol Metab 87; 4942-4945,
2002
52 Simha V, Szczepaniak LS, Wagner AJ, DePaoli AM, Garg A Effect of
leptin replacement on intrahepatic and intramyocellular lipid content
in patients with generalized lipodystrophy Diabetes Care 26: 30-35,
2003
53 Misra
A, Garg A Clinical features and metabolic derangements in
acquired generalized lipodystrophy: case reports and review of the
literature Medicine 82:129-146, 2003
54 Haque WA, Oral EA, Dietz K, Bowcock AM, Agarwal AK, Garg A Risk
factors for diabetes mellitus in familial partial lipodystrophy,
Dunnigan variety Diabetes Care 26:1350-1355, 2003
55 Simha V, Agarwal AK, Oral EA, Fryns J-P, Garg A Genetic
and phenotypic heterogeneity in patients with
mandibuloacral dysplasia associated lipodystrophy J Clin
Endocrinol Metab: 88: 2821-2824, 2003
56 Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O,
Shafeghati Y, Botha EG, Garg A, Hanson NB, Martin GM, Mian
IS, Kennedy BK, Oshima J LMNA mutations in atypical
Werners syndrome Lancet 362:440-445, 2003
57 Agarwal AK, Fryns J-P, Auchus RJ, Garg A Zinc
metalloproteinase, ZMPSTE24, is mutated in mandibuloacral
dysplasia Hum Mol Genet 12; 1995-2001, 2003
58
Kermani A, Garg A Thiazolidinedione-associated congestive
heart failure and pulmonary edema Mayo Clinic Proc 78:1088-
1091, 2003
59 Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, ORahilly
S, Zaidi Z, Gurakan F, Arslanian SA, Klar A, Ricker A,
White NH, Bindl L, Herbst K, Kennel K, Patel SB, Al-Gazali
L, Garg A Phenotypic and genetic heterogeneity in
congenital generalized lipodystrophy J Clin Endocrinol
Metab 88:4840-4847, 2003
60 Simha V, Garg A Phenotypic heterogeneity in body fat
distribution in patients with congenital generalized
lipodystrophy caused by mutations in the AGPAT2 or Seipin
genes J Clin Endocrinol Metab 88:5433-5437, 2003
61 Misra A, Peethambaram A, Garg A Clinical features,
metabolic and autoimmune derangements in acquired partial
lipodystrophy: report of 35 cases and review of literature
Medicine 83; 18-34, 2004
62 Gomes KB, Fernandes AP,
Ferreira ACS, Pardini H, Garg A,
Magré J, Pardini VC Mutations in the Seipin and AGPAT2
genes clustering in consanguineous families with
Berardinelli-Seip Congenital Lipodystrophy from two
separate geographical regions of Brazil J Clin Endocrinol
Metab 89; 357-361, 2004
63 Shah M, Adams-Huet B, Grundy SM, Garg A Effect of a high-
carbohydrate diet vs a high-cis-monounsaturated fat diet on
lipid and lipoproteins in individuals with and without type
2 diabetes Nutr Res 24; 969-979, 2004
64 Haque WA, Garg A, Agarwal AK Enzymatic activity of
naturally-occurring 1-acylglycerol-3-phosphate-O-
acyltransferase 2 AGPAT2 mutants associated with
congenital generalized lipodystrophy Biochem Biophys Res
Comm 327; 446-453, 2005
65 Shah M, Tierney K, Adams-Huet B, Boonyavarakul A, Dinges
WL, Quittner C, Peterson D, Garg A The role of diet,
exercise and
smoking in dyslipidaemia in HIV-infected
patients with lipodystrophy HIV Med 6:291-298, 2005
66 Dinges WL, Chen D, Snell PG, Weatherall PT, Peterson DM,
Garg A Regional body fat distribution in HIV-infected
patients with lipodystrophy J Investig Med 53:15-25, 2005
67 Shackleton S, Smallwood DT, Clayton P, Wilson LC, Agarwal
AK, Garg A, Trembath RC Compound heterozygous ZMPSTE24
mutations reduce prelamin A processing and result in a
severe progeroid phenotype J Med Genet 42: e36, 2005
68 Garg A, Cogulu O, Ozkinay F, Onay H, Agarwal AK A Novel
homozygous Ala529Val LMNA mutation in Turkish patients with
mandibuloacral dysplasia J Clin Endocrinol Metab 90: 5259-
5264, 2005
69 Shah M, Adams-Huet B, Bantle JP, Henry RR, Griver KA, Raatz
SK, Brinkley LJ, Reaven GM, Garg A Effect of a high-
carbohydrate versus a high-cis-monounsaturated fat diet on
blood pressure in patients with type 2 diabetes
Diabetes
Care 28: 2607-2612, 2005
70 Jacob KN, Baptista F, Dos Santos HG, Oshima J, Agarwal AK
and Garg A Phenotypic heterogeneity in body fat
distribution in patients with atypical Werner syndrome due
to R133L Lamin A/C mutation J Clin Endocrinol Metab epub
2005
71 Van Esch H, Agarwal AK, Debeer P, Fryns J-P, Garg A A
homozygous mutation in the lamin A/C gene associated with a
novel syndrome of arthropathy, tendinous calcinosis and
progeroid features J Clin Endocrinol Metab epub 2005
72 Agarwal AK, Zhou XJ, Hall RK, Nicholls K, Bankier A, Van
Esch H, Fryns J-P, Garg A Focal segmental
glomerulosclerosis in patients with mandibuloacral
dysplasia due to zinc metalloproteinase deficiency
submitted
73 Agarwal AK, Barnes RI, Garg A Functional characterization
of human 1-aylglycerol-3-posphate acyltransferase isoform
8: cloning,
tissue distribution, gene structure and
enzymatic activity submitted
74 Jacob KN, Vuitch F, Euhus D, Garg A Unilateral
enophthalmos due to localized lipodystrophy of orbital
adipose tissue in a patient with discoid lupus
erythematosus associated panniculitis submitted
SOLICITED PUBLICATIONS IN JOURNALS
1 Ahuja MMS, Garg A Semantics in diabetes mellitus: Impaired glucose
tolerance J Assoc Physicians India 31 1: 7-8, 1983
2 Ahuja MMS, Dhar SN, Sapru RP, Prakash C, Natarajan V, Arora A, Garg
A, Paul Anand M, Bisht DB Art of teaching J Assoc Physicians India
31 10: 651-653, 1983
3 Boshell BR, Garg A Update - treatment of diabetes mellitus
Todays Therapeutic Trends 2 1: 17-34, 1984
4 Garg A, Grundy SM Treatment of dyslipidemia in non-insulin-
dependent diabetes mellitus Cardiovascular Reviews Reports 9: 30-39,
1988
5 Garg A, Grundy SM Treatment of dyslipidemia in non-insulin-
dependent diabetes mellitus with lovastatin Am J Cardiol 62: 44J-49J,
1988
6 Garg A, Grundy
SM Lovastatin therapy for reducing plasma
cholesterol levels in elderly diabetic patients Geriatric Medicine
Today 8: 58-66, 1989
7 Garg A, Grundy SM Therapeutic perspectives in hyperlipidemic
patients with diabetes mellitus J Diabetic Complications 4: 72-74,
1990
8 Grundy SM, Vega GL, Garg A Use of 3-hydroxy-3-methylglutaryl
coenzyme A reductase inhibitors in various forms of dyslipidemia Am
J Cardiol 66: 31B-38B, 1990
9 Garg A, Grundy SM Management of dyslipidemia in NIDDM Diabetes
Care 13:153-169, 1990
10 Garg A Dietary recommendations for patients with non-insulin-
dependent diabetes mellitus Compr Ther 17: 25-31, 1991
11 Garg A Lipoprotein metabolism in diabetes mellitus: effects of diet
and drugs Proceedings of the Diabetes mellitus and lipid metabolism
research seminar Japan Diabetes-Lipid Society 8: 117-132, 1992
12 Garg A, Grundy SM Should NIDDM patients be on high-carbohydrate,
low-fat diets? No Hospital Practice 27; Suppl 1: 11-14, 1992
13 Garg A Lipid-lowering therapy and macrovascular disease in diabetes
mellitus
Diabetes 41: suppl 2: 111-115, 1992
14 Garg A High cholesterol in diabetic patients: how can it be
lowered? Internal Medicine 13: 28-31, 1992
15 Garg A Dietary monounsaturated fatty acids for patients with
diabetes mellitus Ann NY Acad Sci 683: 199-206, 1993
16 Garg A Commentary Diabetes Spectrum 6:308-309, 1993
17 Garg A High-monounsaturated fat diet for diabetic patients Is it
time to change the current dietary recommendations? Diabetes Care 17:
242-246, 1994
18 Garg A Efficacy of dietary fiber in lowering serum cholesterol Am
J Med Editorial 97: 501-503, 1994
19 Garg A Management of dyslipidemia in IDDM patients Diabetes Care
17: 224-234, 1994
20 Abate N, Garg A Heterogeneity in adipose tissue metabolism: causes,
implications and management of regional adiposity Prog Lipid Res
34:53-70, 1995
21 Garg A, Whelan M, Barnett J Monounsaturates may be your best choice
for meal plan Diabetes in the News 10:16-18, 1991
22 Garg A Commentary How I treat dyslipidemia in diabetes mellitus
Clinical Diabetes 13:89-90, 1995
23 Garg A, Grundy SM Treatment of
dyslipidemia in patients with non-
insulin-dependent diabetes mellitus Diabetes Reviews 3:433-445,
1995
24 Garg A Optimum dietary therapy for patients with non-insulin-
dependent diabetes mellitus The Endocrinologist 6:30-36, 1996
25 Garg A, Haffner SM Insulin resistance and atherosclerosis: an
overview Diabetes Care 19:274, 1996
26 Garg A Insulin resistance in the pathogenesis of dyslipidemia
Diabetes Care 19:387-389, 1996
27 Shah M, Garg A High-fat and high-carbohydrate diets and energy
balance Diabetes Care 19:1142-1152, 1996
28 Misra A, Garg A Leptin, its receptor and obesity J Investig Med
44:540-548, 1996
29 Garg A, Grundy SM Diabetic dyslipidemia and its therapy Diabetes
Reviews 5:425-433, 1997
30 Cater NB, Garg A Serum low-density lipoprotein cholesterol response
to modification of saturated fat intake: recent insights Current
Opinion in Lipidology 8:332-336, 1997
31 Barnett JP, Garg A Medical nutrition therapy for patients with
diabetes mellitus - role of dietary fats On the Cutting Edge:
Diabetes Care and
Education 18:5-6, 1997
32 Garg A High-monounsaturated-fat diets for patients with diabetes
mellitus: a meta-analysis Am J Clin Nutr 67 suppl; 577S-582S,
1998
33 Garg A Treatment of diabetic dyslipidemia Am J Cardiol 81 4A:47B-
51B, 1998
34 Garg A Dyslipoproteinemia and diabetes Endocrinol Metab Clin N Am
27:613-625, 1998
35 Garg A Lipodystrophies Am J Med 108:143-152, 2000
36 Chen D, Garg A Monogenic disorders of obesity and body fat
distribution J Lipid Research 40: 1735-1746, 1999
37 Cater NB, Garg A The effect of dietary intervention on serum lipid
levels in type 2 diabetes mellitus Current Diabetes Reports 2: 289-
294, 2002
38 Garg A, Misra A Hepatic steatosis, insulin resistance and adipose
tissue disorders Editorial J Clin Endocrinol Metab 87: 3019-3022,
2002
39 Chen D, Misra A, Garg A Lipodystrophy in human immunodeficiency virus-
infected patients J Clin Endocrinol Metab 87; 4845-4856, 2002
40 Agarwal AK, Garg A Molecular basis of congenital generalized
lipodystrophy: significance of triglyceride biosynthetic pathways
Trends
Endocrinol Metab 14:214-221, 2003
41 Haque WA, Garg A Adipocyte biology and adipocytokines Clin Lab Med
24; 217-234, 2004
42 Agarwal AK, Barnes RI, Garg A Genetic basis of congenital generalized
lipodystrophy Int J Obesity 28; 336-339, 2004
43 Garg A, Misra A Lipodystrophies: rare disorders causing metabolic
syndrome Endocrinol Metab Clin N Am 33; 305-331, 2004
44 Garg A Regional adiposity and insulin resistance J Clin Endocrinol
Metab 89; 4206-4210, 2004
45 Agarwal AK, Garg A Seipin: a mysterious protein Trends
Mol Med 10:440-444, 2004
46 Garg A Acquired and inherited lipodystrophies N Engl J
Med 350: 1220-1234, 2004
47 Garg A Statins for all patients with type 2 diabetes: not so soon
Lancet 364:641-642, 2004
48 Agarwal AK, Garg A Genetic basis of lipodystrophies and management of
metabolic complications Ann Rev Med in press 2005
49 Jacob KN, Garg A Laminopathies: multisystem dystrophy syndromes Mol
Genet Metab in press
50 Garg A Adipose Tissue Dysfunction in Obesity and Lipodystrophy
Clinical Cornerstone in press
51
Agarwal AK, Garg A Molecular Genetic Basis of Lipodystrophy
Syndromes Ann Rev Genomics Human Genet submitted for publication
BOOK CHAPTERS
1 Garg A, Grundy SM Hypolipidemic therapy for dyslipidemia in
patients with non-insulin-dependent diabetes mellitus In: Gotto AM
Jr, Smith LC eds, Drugs affecting lipid metabolism X Elsevier
Science Publishers BV, Amsterdam, pp 427-430, 1990
2 Garg A, Grundy SM Treatment of diabetic dyslipidemia with
lovastatin In: Brownlee M, Sherwood LM eds, Diabetes mellitus and
its complications: Pathogenesis and treatment Hanley Belfus, Inc
PA pp 269-280, 1990
3 Grundy SM, Garg A Cardiovascular actions of fish oils and omega-3
fatty acids In: Zipes DP, Rowlands DJ eds, Progress in Cardiology
Lea Febiger Philadelphia, PA vol 4, pp 21-37, 1991
4 Garg A, Grundy SM Dyslipidemia as an insulin resistant disorder
In: Smith U, Bruun NE, Hedner T, Hokfelt B eds Hypertension as an
insulin-resistant disorder - genetic factors and cellular mechanisms
Elsevier Science Publishers BV, Amsterdam, pp 301-319, 1991
5 Garg
A Role of monounsaturated fatty acids in nutrition for
patients with non-insulin-dependent diabetes mellitus In: Rifkin H,
Colwell JA, Taylor SI eds Diabetes 1991 Proceedings of the 14th
International Diabetes Federation Congress, Washington DC, 23-28
June 1991 Elsevier Science Publishers BV, Amsterdam, pp 809-813,
1991
6 Garg A, Grundy SM Management of hyperlipidemias in diabetes
mellitus In: Kochupillai N ed Advances in Endocrinology,
Metabolism and Diabetes Volume 1 Proceedings of the India-USA
Symposium on Endocrinology, Metabolism Diabetes–EMD 1990
Macmillan India Delhi, pp 44-53, 1992
7 Garg A, Grundy SM Clinical picture and therapy of dyslipidemia in
diabetes mellitus In: Draznin B, Eckel RH eds Diabetes and
atherosclerosis: molecular basis and clinical aspects Elsevier New
York, NY pp 119-144, 1993
8 Garg A Novel dietary therapies for patients with diabetes mellitus
In: Harper AE ed Type II Diabetes: Glucose homeostasis,
complications and novel therapies Report of the Fourteenth Ross
Conference on Medical Research Ross Columbus, Ohio pp 52-57, 1995
9 Garg A The use of olive oil in the diabetic diet In: World Olive
Encyclopedia International Olive Oil Council EGEDSA, Sabadell, Spain
pp 376-377, 1996
10 Garg A Management of hypertriglyceridemia Clinical Endocrinology
Update 1997 Syllabus: The Endocrine Society Press Bethesda, MD pp
329-334, 1997
11 Garg A The role of body fat distribution in insulin resistance In:
Reaven GM, Laws A eds Insulin Resistance; The Metabolic Syndrome X
The Humana Press Totowa, NJ pp 83-96, 1999
12 Cater N, Garg A Diabetes and dyslipidemias In: Taylor SI ed
Current Review of Diabetes Current Medicine, Philadelphia, PA pp 131-
140, 1999
13 Barnett J, Garg A Optimum dietary approach in type 2 diabetes In:
Betteridge DJ ed Diabetes: Current Perspectives Martin Dunitz
London, UK pp 317-340, 2000
14 Garg A The lipodystrophies and other rare disorders of adipose
tissue In: Braunwald E, Fauci AS, Kasper DL, Hauser SI, Longo DL,
Jameson JL eds Harrisons Principles of Internal Medicine 15th
Edition McGraw
Hill, New York, NY pp 2316-2319, 2001
15 Garg A, Barnett JP Nutritional management of the person with
diabetes In: Porte D, Jr, Sherwin RS, Baron A eds Ellenberg and
Rifkins Diabetes Mellitus 6th Edition McGraw Hill, New York, NY pp
437-452, 2003
16 Garg A Acquired Generalized Lipodystrophy In: The NORD Guide to Rare
Disorders Lippincott, Williams Wilkins Philadelphia, PA pp 320-
321, 2003
17 Garg A Acquired Partial Lipodystrophy In: The NORD Guide to Rare
Disorders Lippincott, Williams Wilkins Philadelphia, PA pp 321,
2003
18 Garg A Congenital Generalized Lipodystrophy In: The NORD Guide to
Rare Disorders Lippincott, Williams Wilkins Philadelphia, PA pp
322, 2003
19 Garg A Familial Partial Lipodystrophy In: The NORD Guide to Rare
Disorders Lippincott, Williams Wilkins Philadelphia, PA pp 323,
2003
20 Garg A Misra A Lipodystrophies and Diabetes In: DeFronzo RA,
Ferrannini E, Zimmet P eds International Textbook of Diabetes
Mellitus 3rd Edition Wiley, NY pp 655-672
21 Garg A, Barnett JP Nutritional management of the person with
diabetes In:
Inzucchi S, Porte D, Jr, Sherwin RS, Baron A eds The
Diabetes Mellitus Manual: A Primary Care Companion to Ellenberg and
Rifkins Sixth Edition McGraw Hill, New York, NY pp 96-108, 2005
22 Barnett JP, Garg A Preventing cardiovascular complications in
diabetes In: Carson JA, Burke FM, Hark LA eds Cardiovascular
Nutrition: Disease Management and Prevention American Dietetic
Association, Chicago, IL pp 189-211
23 Garg A Lipodystrophic syndromes Meet-The-Professor Handouts: The
Endocrine Society Press Bethesda, MD pp 165-170, 2004
24 Garg A Lipodystrophy epidemiology and new syndromes In 12th
International Congress of Endocrinology-12th ICE: Medimond Lisbon, pp
133-140, 2004
25 Garg A Lipodystrophy syndromes Meet-The-Professor Handouts: The
Endocrine Society Press Bethesda, MD pp 161-166, 2005
26 Garg A Genetic Lipodystrophies In Rimoin DL, Connor JM, Pyeritz RE,
Korf B eds Emery and Rimoins Principles and Practice of Medical
Genetics, 5th Edition Elsevier in press
ABSTRACTS AND LETTERS TO THE EDITOR
1 Garg A, Kansal PC, Boshell BR Determination of daily insulin
dose
by Biostator and subcutaneous insulin infusion pump SIIP vs
conventional method Diabetes 33 suppl 107A, 1984
2 Garg A, Grizzle WE, Stabler TV, Boots LR, Boshell BR, Kansal PC
Adrenomedullary responses of patients with hypopituitarism to insulin
induced hypoglycemia Abstract presented at the annual meeting of The
Endocrine Society, Baltimore, Maryland, 1985
3 Garg A, Bonanome A, Grundy SM Comparison of high monounsaturated
fat and high carbohydrate diets for NIDDM Diabetes 36 Suppl 1:
11A, 1987
4 Garg A, Grundy SM Lovastatin therapy for cholesterol lowering in
non- insulin dependent diabetes mellitus NIDDM Clin Res 35 3:
503A, 1987
5 Garg A, Grundy SM Gemfibrozil GEM alone or in combination with
lovastatin LOV; HMG-CoA reductase inhibitor for lipid lowering in
hypertriglyceridemic patients with NIDDM Diabetes 37 Suppl 1: 39A,
1988
6 Garg A Nicotinic acid NA therapy for treatment of dyslipidemia in
non-insulin-dependent diabetes mellitus NIDDM Advantages and
drawbacks Arteriosclerosis 8: 581a, 1988
7 Beil FU, Vega GL,
Ma PA, Garg A, Grundy SM Lipoprotein kinetics in
betasitosterolemia Arteriosclerosis 8: 587a, 1988
8 Garg A, Helderman JH, Grundy SM, Koffler M, Unger RH Insulin
resistance underlies primary hypertriglyceridemia Clin Res 37:449A,
1989
9 Garg A, Grundy SM Nicotinic acid may not be first line therapy for
dyslipidemia in non-insulin-dependent diabetes mellitus NIDDM Clin
Res 37:449A, 1989
10 Garg A, Grundy SM, Helderman JH, Unger RH High carbohydrate diets
do not induce insulin sensitivity in NIDDM patients Diabetes 38
Suppl 2:46A, 1989
11 Nozaki S, Garg A, Vega GL, Grundy SM Effects of omega-3
polyunsaturated fatty acids on plasma lipoproteins and postheparin
lipolytic activity in patients with hypertriglyceridemia X
International Symposium on Drugs Affecting Lipid Metabolism, 112,
1989
12 Garg A, Grundy SM High monounsaturated fat diet for non-insulin-
dependent diabetes mellitus letter to the Editor N Engl J Med 320:
536-37, 1989
13 Garg A, Fleckenstein JL, Peshock RM, Grundy SM Peculiar localization
of adipose
tissue in patients with congenital lipodystrophy Clin Res
38: 396A, 1990
14 Garg A, Stray-Gundersen J, Bertocci LA, Parsons D, Fleckenstein JL,
Peshock RM, Grundy SM Skeletal muscle morphology and exercise
response in congenital lipodystrophy Clin Res 38: 556A, 1990
15 Garg A, Grundy SM, Koffler M Induction of hyperglycemia by high
carbohydrate diets in NIDDM: Effects on islet cell function Diabetes
39: Suppl 1: 63A, 1990
16 Fleckenstein JL, Garg A, Vuitch M, Faber T, McColl R, Opperman R,
Peshock RM Bone lesions in congenital lipodystrophy: MRI evaluation
Proceedings of the American Roentgen Ray Society, 1990
17 Garg A, Grundy SM Nicotinic acid in NIDDM letter to the Editor
JAMA 264: 2995-2996, 1990 Errata published in JAMA 265: 2672, 1991
18 Farese RV Jr, Garg A, Pierotti VR, Vega GL, Young SG, Grundy SM A
truncated species of apolipoprotein B, Apo B83, associated with
hypobetalipoproteinemia Clin Res 39: 276A, 1991
19 Garg A, Stray-Gundersen J, Bertocci LA, Parsons D, Fleckenstein JL,
Peshock RM, Grundy SM Skeletal muscle morphology and
exercise
response in congenital lipodystrophy CL Diabetes 40 suppl 1: 31A,
1991
20 Enas E, Davidson MA, Garg A, VM Nair, Yusuf S Prevalence of
coronary heart disease CHD and its risk factors in Asian Indian
migrants to the United States International Atherosclerosis Society
9th International Symposium on Atherosclerosis, October 6-11, 1991,
Chicago: 267, 1991
21 Garg A, Grundy SM Cholestyramine therapy for dyslipidemia in NIDDM
Clin Res 40: 239A, 1992
22 Garg A, Reaven GM, Bantle JP, Griver K, and the Multicenter Diet
Study Group Long term effects of high-carbohydrate versus high-
monounsaturated- fat diets in NIDDM Diabetes 41 suppl 1: 72A,
1992
23 Blades B, Garg A Mechanisms of high-carbohydrate diet induced
hypertriglyceridemia in patients with non-insulin-dependent diabetes
mellitus Accepted for presentation at the Australian Atherosclerosis
Society Meeting, Brisbane, Australia, 1992
24 Garg A Diabetes mellitus and monounsaturated fatty acids Program
and Abstracts of the International Symposium on Dietary Lipids and
Insulin Action Smolenice Castle, Czecho-Slovakia: pp 69-70 1992
25 Abate N, Garg A, Vega GL, Grundy SM Atherogenic lipoprotein pattern
in normolipidemic patients with mild NIDDM Clin Res 41: 299A, 1993
26 Abate N, Garg A, Grundy SM Heterogeneity in the pathophysiology of
NIDDM Diabetes 42 suppl 1: 241A, 1993
27 Garg A, Fleckenstein JL, Abate N Insulin resistance and body fat
distribution in a male patient with familial partial lipodystrophy
FPL Clin Res 42: 199A, 1994
28 Abate N, Garg A, Stray-Gundersen J, Peshock RM, Grundy SM Predictive
value of anthropometric measurements for the estimation of
intraperitoneal adipose tissue mass in men Clin Res 42: 174A, 1994
29 Chandalia M, Vuitch FM, Garg A Severe amylin deposition in
pancreatic islets in congenital generalized lipodystrophy CGL Clin
Res 42: 199A, 1994
30 Abate N, Burns D, Peshock RM, Garg A, Grundy SM Quantitation of
adipose tissue mass by magnetic resonance imaging MRI: validation
against dissection in human cadavers Clin Res 42: 174A, 1994
31 Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy
SM Abdominal
obesity and insulin resistance in non-diabetic men Diabetes 43 suppl
1: 88a, 1994
32 Garg A Varying carbohydrate intake in NIDDM JAMA letter to the
Editor 272:1818, 1994
33 Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM Regional
adiposity and insulin resistance in Asian Indian migrant men to the
United States J Investig Med 43 suppl 2: 303A, 1995
34 Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM Regional
adiposity in patients with NIDDM Diabetes 44 suppl 1: 8A, 1995
35 Abate N, Garg A, Peshock RM, Grundy SM Prediction of abdominal
adipose tissue masses using a single axial magnetic resonance imaging
MRI slice in men J Investig Med 43 suppl 2: 244A, 1995
36 Garg A The Postmenopausal Estrogen/Progestin Interventions Trial
JAMA letter to the Editor 274:1675-1676, 1995
37 Chandalia M, Garg A, Grundy SM, Brinkley L Effects of dietary fiber
on glycemia and lipoproteins in NIDDM Diabetes 45 suppl 2: 332A,
1996
38 Jialal I, Li D, Fuller C, Garg A, Devaraj S Alpha-tocopherol
decreases LDL oxidation but not glycation
Diabetes 45 suppl 2:
90A, 1996
39 Garg A Response to the letter to the Editor Indian Heart J 1996
40 Stein DT, Szczepaniak L, Garg A, Malloy C, McGarry JD Intramuscular
lipid is increased in subjects with congenital generalized
lipodystrophy Diabetes 46 suppl 1: 242A, 1997
41 Peters JM, Barnes B, Gitomer W, Bennett L, Garg A, Bowcock AM
Linkage mapping of a gene for familial partial lipodystrophy to
chromosome 1p11-q24 Am J Human Genet 61 suppl A291, 1997
42 Stein DT, Szczepaniak LS, Schick F, Garg A, McGarry JD Validation of
proton MRS measurement of intracellular lipids in vivo International
Society for Magnetic Resonance in Medicine Book of Abstracts; p 1333,
1997
43 Garg A Lipodystrophies Endo99, San Diego, p 25-26, 1999
44 Chen D, Garg A Regional adipose tissue distribution in multiple
symmetric lipomatosis MSL Endo99, San Diego, p 452, 1999
45 Speckman RA, Garg A, Bowcock AM Familial partial lipodystrophy
FPLD, Emery-Dreifuss muscular dystrophy and dilated cardiomyopathy
and conduction-system disease D-CM; lamin A/C mutation and clinical
overlap American Society of Human Genetics Meeting 2000 abstract no
2178
46 Simha V, Garg A Phenotypic characteristics of patients with
mandibuloacral dysplasia associated lipodystrophy 1st International
Workshop on Lipoatrophic diabetes and other syndromes of
lipodystrophy NIH, Bethesda, Maryland, p 57, 2001
47 Garg A Overview of Clinical Syndromes of Lipodystrophies 1st
International Workshop on Lipoatrophic diabetes and other syndromes of
lipodystrophy NIH, Bethesda, Maryland, p 8-9, 2001
48 Bowcock AM, Speckmann R, Helms C, Garg A Cloning genes for the
inherited lipodystrophies 1st International Workshop on Lipoatrophic
diabetes and other syndromes of lipodystrophy NIH, Bethesda,
Maryland, p14, 2001
49 Arioglu E, Simha V, Andewelt A, Ruiz E, Snell P, Depaoli A, Wagner A,
Reitman M, Taylor SI, Gorden P, Garg A Treatment of patients with
lipoatrophy: efficacy of leptin replacement 1st International
Workshop on Lipoatrophic diabetes and other syndromes of
lipodystrophy NIH, Bethesda, Maryland, p18-19, 2001
50
Dinges WL, Chen D, Agyarko A, Weatherall P, Peterson D, Garg A Body
composition assessment of HIV-associated lipodystrophy Submitted to
XIV International AIDS Conference, Barcelona, Spain, July 2002
51 Simha V, Szczepaniak LS, Garg A Effect of leptin replacement on
intrahepatic and intramyocellular lipid content in patients with
generalized lipodystrophy Abstract submitted to the 62nd Annual
Meeting of the American Diabetes Association, San Francisco, June
2002
52 Haque EA, Oral EA, Dietz K, Bowcock AM, Garg A Risk factors for
diabetes in familial partial lipodystrophy, Dunnigan variety FPLD
Abstract submitted to the Endocrine Society Meeting, San Francisco,
June 2002
53 Oshima J, Garg A, Martin GM, Kennedy BK LMNA mutations in
atypical Werners syndrome Reply Lancet 362:1586, 2003
54 Kermani A, Garg A Thiazolidinedione-associated congestive
heart failure and pulmonary edema Reply Mayo Clinic Proc
79:575-577, 2004
55 Garg A Acquired and inherited lipodystrophies N Engl J
Med 351: 103-104, 2004
———————–
2
